President-elect Trump has selected the surgeon and television personality Mehmet Oz as the administrator of the Centers for ...
Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...
The FDA rejected an application from Astellas seeking to change the prescribing label for its eye drug Izervay to allow less ...
Even as more health systems adopt ambient scribes, the technology providers might find it harder to differentiate themselves, ...
Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast
Jupiter has raised $70 million from investors including Mission BioCapital and the Mayo Clinic to start small biotechs that ...
More pharma companies are tailoring their business models to focus on low-income countries. But a new analysis finds overall ...
Merck's new formulation could help secure a larger share of Keytruda's sales after the cancer drug's U.S. patent expires in ...
Robert F. Kennedy Jr.'s nonprofit, Children’s Health Defense, is involved in vaccine lawsuits against agencies he could wind ...
The FDA's digital health advisory committee is expected to weigh in on how generative AI should be regulated by the agency.
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...
LONDON — Robert F. Kennedy Jr. has been a vocal critic of the pharma industry. He’s said it’s corrupted U.S. health agencies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback